A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors

Stopped The study was terminated due to the sponsor's research and development strategy adjustment.

Conditions

• Advanced Solid Tumor

Interventions

• DRUG: Envofolimab
• DRUG: BD0801
• DRUG: Docetaxel
• DRUG: Irinotecan
• DRUG: Leucovorin calcium
• DRUG: 5-Fluorouridine

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.